GWPH News and Press, GW Pharmaceuticals Plc From 10/28/20

Investors should study the various revenue streams for "epidiolex". Level of cash reserves important to judge likelihood of future share dilution. Comments at analyst call on future product developments probably the most important look-out. Earnings may give indication of abil...

LONDON and CARLSBAD, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid pro...

GW Pharmaceuticals (GWPH) has been trending lower since its last earnings report, but the stock's price doesn't reflect its revenue potential. Read more to learn if you should purchase the stock ahead of its upcoming earnings report. GW Pharmaceuticals ( GWPH ) has had a disappointin...

-- Technology p rovide s a n ew w ay for the community to c ommunicate and c onnect -- -- Launching in collaboration with patient advocacy organizations, this web-based, i mage-recognition t echnology ...

FinancialBuzz.com News Commentary New York, NY (10/5/2020) – Presently, the medical cannabis sector accounts for the majority of the market share, and progress is slowly being made in removing the stigmas associated with such products. For example, the U.S. Food and Drug Administ...

Four not-widely-followed biotech stocks were pitched at the recent Ira Sohn conference. Below is the full audio of the pitches, and a list of the publicly-traded landscape for each. For further details see: These Are The Four Biotech Stocks Recently Pitched At The Ira Sohn Conference

The combined market capitalization of the five largest Canada-centric cannabis companies is down 89.6% or $77 billion from their peak. The 15 largest non-Canada centric stocks have a combined capitalization of only $17.7 billion. Investors looking for 10 baggers in cannabis compan...

Last week was a tough week for cannabis stocks as ETFs plummeted with disappointing earnings reports. The ETFMG Alternative Harvest ETF (NYSE: MJ), the AdvisorShares Pure Cannabis ETF (NYSE: YOLO),  The Cannabis ETF (NYSE: THCX), the Amplify Seymour Cannabis ETF (NYSE: CNBS) all lost a...

The markets are struggling of late, and while that might be suboptimal if you're holding stocks, it's a great opportunity if you're a buyer. Purchasing stocks at a reduced price can increase the potential returns you make over the long term. And with the S&P 500 falling more than 8%...

GW Pharmaceuticals (GWPH) announces that the Australian Therapeutic Goods Administration ((TGA)) has approved EPIDYOLEX (cannabidiol) for the treatment of seizures associated with Lennox-Gastaut syndrome ((LGS)) or Dravet syndrome ((DS)) in patients two years of age and older.LGS/DS...